Atria Wealth Solutions Inc. Trims Holdings in Procter & Gamble Company (The) $PG

Atria Wealth Solutions Inc. lowered its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 58.6% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 55,657 shares of the company’s stock after selling 78,669 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in Procter & Gamble were worth $8,880,000 as of its most recent filing with the SEC.

Several other large investors have also recently added to or reduced their stakes in the company. Stableford Capital II LLC raised its holdings in Procter & Gamble by 1.1% during the first quarter. Stableford Capital II LLC now owns 5,817 shares of the company’s stock worth $993,000 after purchasing an additional 61 shares in the last quarter. B & T Capital Management DBA Alpha Capital Management increased its holdings in Procter & Gamble by 2.3% in the first quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company’s stock valued at $476,000 after buying an additional 63 shares in the last quarter. Private Management Group Inc. increased its holdings in Procter & Gamble by 4.8% in the first quarter. Private Management Group Inc. now owns 1,384 shares of the company’s stock valued at $236,000 after buying an additional 64 shares in the last quarter. Lantz Financial LLC increased its holdings in Procter & Gamble by 1.2% in the second quarter. Lantz Financial LLC now owns 5,237 shares of the company’s stock valued at $834,000 after buying an additional 64 shares in the last quarter. Finally, Orca Investment Management LLC increased its holdings in Procter & Gamble by 2.0% in the second quarter. Orca Investment Management LLC now owns 3,238 shares of the company’s stock valued at $516,000 after buying an additional 64 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

PG has been the subject of a number of research analyst reports. Evercore ISI reaffirmed an “in-line” rating and issued a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. BNP Paribas Exane dropped their target price on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a report on Tuesday, September 23rd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Procter & Gamble in a report on Wednesday, October 8th. Bank of America dropped their target price on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Finally, Wells Fargo & Company dropped their price objective on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research note on Thursday, September 25th. Eleven equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $172.21.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CEO Jennifer L. Davis sold 3,227 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $491,246.21. Following the completion of the sale, the chief executive officer directly owned 61,764 shares of the company’s stock, valued at approximately $9,402,333.72. The trade was a 4.97% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Shailesh Jejurikar sold 3,986 shares of Procter & Gamble stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $606,788.78. Following the completion of the transaction, the chief operating officer owned 46,899 shares in the company, valued at approximately $7,139,434.77. This trade represents a 7.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold 149,763 shares of company stock worth $23,421,279 in the last three months. 0.20% of the stock is currently owned by company insiders.

Procter & Gamble Trading Down 1.4%

Shares of PG opened at $147.54 on Tuesday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The firm has a 50 day simple moving average of $155.18 and a 200-day simple moving average of $159.27. Procter & Gamble Company has a 1-year low of $146.96 and a 1-year high of $180.43. The stock has a market cap of $345.32 billion, a price-to-earnings ratio of 22.66, a price-to-earnings-growth ratio of 3.97 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last released its earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.42 by $0.06. The firm had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. Procter & Gamble’s revenue for the quarter was up 1.7% on a year-over-year basis. During the same period in the previous year, the company earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.